Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

EHRA - PATHS

Financiado

Cerrado

Addressing multimorbidity in elderly atrial fibrillation patients through interd...

Addressing multimorbidity in elderly atrial fibrillation patients through interdisciplinary tailored patient centered care pathways Optimization of atrial fibrillation (AF) disease management is highly needed. The AF prevalence is 7.8% above the age of 65 years and it will further increase as the population ages and predisposing factors become more prevalent.... ver más

31/03/2026

ESC/ SEC

6M€

Presupuesto del proyecto: 6M€

Líder del proyecto

SOCIETE EUROPEENNE DE CARDIOLOGIE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 17 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-01-22

SC1-BHC-24-2020: Healthcare interventions for the ma...

I+D

Cerrada hace 5 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

17 Participantes

ESC/ SEC

516.75K€ | Lider

PEREZ LINARES

169.44K€ | Participante

UCC

154.14K€ | Participante

KINGS COLLEGE LONDON

88.67K€ | Participante

Proyectos interesantes

AFFIRMO

Medical Technol...

Data Science

6M€ Cerrado

AFFECT-EU

Medical Technol...

Data Science

8M€ Cerrado

DPI2017-83952-C3-3-R

Medical Technol...

Data Science

178K€ Cerrado

DPI2017-83952-C3-1-R

Medical Technol...

Data Science

157K€ Cerrado

MMAF

Medical Technol...

Data Science

2M€ Cerrado

GUIDE-AF

Medical Technol...

Data Science

204K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 62 meses Fecha Inicio: 2021-01-22
Fecha Fin: 2026-03-31

Líder del proyecto

SOCIETE EUROPEENNE DE CARDIOLOGIE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 6M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Optimization of atrial fibrillation (AF) disease management is highly needed. The AF prevalence is 7.8% above the age of 65 years and it will further increase as the population ages and predisposing factors become more prevalent. Multimorbidity (93.5%) and polypharmacy (76.5%) are very common in these patients. The mean number of comorbidities is 5.0 in those ≥65 years old. There is a great need to optimize the management of AF patients - and not only the arrhythmia - to reduce the burden on patients, society, healthcare system and the economy. The aim of the EHRA-PATHS project is to create well founded, innovative systematic care pathways to tackle multimorbidity in elderly AF patients. We hypothesize that such a well-structured, interdisciplinary, and patient-tailored care program is feasible throughout all healthcare systems in Europe, and effective to optimize outcomes. There are 5 objectives: 1. Further characterize multimorbidity, polypharmacy and sex differences in AF patients by means of clinical data registries. 2. Perform a European needs assessment study to map current clinical practice and identify unmet needs concerning multimorbid AF patient management. 3. Devise and implement new software-supported interdisciplinary, patient-centred care pathways to detect, manage, and follow-up on multimorbidity and polypharmacy in elderly AF patients with a focus on each patient’s unique profile. 4. A two-part evaluation with an initial base mapping followed by a European cluster randomised controlled trial to evaluate the newly developed holistic care paths with predefined key performance indicators. A cost-utility analysis will be included. 5. Disseminate the insights, care pathways and implementation strategy from this project to patients, physicians, hospitals, other healthcare providers and regulatory authorities. The consortium combines extensive expertise from multiple specialties with the support of ESC and EHRA to impact outcomes of multimorbid AF patients.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores